These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 17164353)

  • 1. Hypoxia-inducible factor 1 as a possible target for cancer chemoprevention.
    López-Lázaro M
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2332-5. PubMed ID: 17164353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silibinin inhibits hypoxia-inducible factor-1alpha and mTOR/p70S6K/4E-BP1 signalling pathway in human cervical and hepatoma cancer cells: implications for anticancer therapy.
    García-Maceira P; Mateo J
    Oncogene; 2009 Jan; 28(3):313-24. PubMed ID: 18978810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting the hypoxia-inducible factor (HIF) pathway in cancer.
    Poon E; Harris AL; Ashcroft M
    Expert Rev Mol Med; 2009 Aug; 11():e26. PubMed ID: 19709449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of hypoxia-inducible factor-1alpha as a cancer therapy target.
    Patiar S; Harris AL
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S61-75. PubMed ID: 17259560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
    Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
    Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting hypoxia cell signaling for cancer therapy.
    Melillo G
    Cancer Metastasis Rev; 2007 Jun; 26(2):341-52. PubMed ID: 17415529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual role of hydrogen peroxide in cancer: possible relevance to cancer chemoprevention and therapy.
    López-Lázaro M
    Cancer Lett; 2007 Jul; 252(1):1-8. PubMed ID: 17150302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular redox status regulates hypoxia inducible factor-1 activity. Role in tumour development.
    Martínez-Sánchez G; Giuliani A
    J Exp Clin Cancer Res; 2007 Mar; 26(1):39-50. PubMed ID: 17550131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. YC-1 inhibits HIF-1 expression in prostate cancer cells: contribution of Akt/NF-kappaB signaling to HIF-1alpha accumulation during hypoxia.
    Sun HL; Liu YN; Huang YT; Pan SL; Huang DY; Guh JH; Lee FY; Kuo SC; Teng CM
    Oncogene; 2007 Jun; 26(27):3941-51. PubMed ID: 17213816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A quassinoid 6alpha-tigloyloxychaparrinone inhibits hypoxia-inducible factor-1 pathway by inhibition of eukaryotic translation initiation factor 4E phosphorylation.
    Jin X; Jin HR; Lee D; Lee JH; Kim SK; Lee JJ
    Eur J Pharmacol; 2008 Sep; 592(1-3):41-7. PubMed ID: 18639543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel benzimidazole analogue inhibits the hypoxia-inducible factor (HIF)-1 pathway.
    Won MS; Im N; Park S; Boovanahalli SK; Jin Y; Jin X; Chung KS; Kang M; Lee K; Park SK; Kim HM; Kwon BM; Lee JJ; Lee K
    Biochem Biophys Res Commun; 2009 Jul; 385(1):16-21. PubMed ID: 19433063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia-inducible factor 1 inhibitors.
    Melillo G
    Methods Enzymol; 2007; 435():385-402. PubMed ID: 17998065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-inducible factor-1alpha-induced differentiation of myeloid leukemic cells is its transcriptional activity independent.
    Song LP; Zhang J; Wu SF; Huang Y; Zhao Q; Cao JP; Wu YL; Wang LS; Chen GQ
    Oncogene; 2008 Jan; 27(4):519-27. PubMed ID: 17637739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell type-specific, topoisomerase II-dependent inhibition of hypoxia-inducible factor-1alpha protein accumulation by NSC 644221.
    Creighton-Gutteridge M; Cardellina JH; Stephen AG; Rapisarda A; Uranchimeg B; Hite K; Denny WA; Shoemaker RH; Melillo G
    Clin Cancer Res; 2007 Feb; 13(3):1010-8. PubMed ID: 17289897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-inducible transcription factors and their role in renal disease.
    Eckardt KU; Bernhardt W; Willam C; Wiesener M
    Semin Nephrol; 2007 May; 27(3):363-72. PubMed ID: 17533012
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCAAT/enhancer-binding protein alpha antagonizes transcriptional activity of hypoxia-inducible factor 1 alpha with direct protein-protein interaction.
    Yang L; Jiang Y; Wu SF; Zhou MY; Wu YL; Chen GQ
    Carcinogenesis; 2008 Feb; 29(2):291-8. PubMed ID: 18024476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High frequency of HIF-1alpha overexpression in BRCA1 related breast cancer.
    van der Groep P; Bouter A; Menko FH; van der Wall E; van Diest PJ
    Breast Cancer Res Treat; 2008 Oct; 111(3):475-80. PubMed ID: 18030615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional antibodies produced by oncolytic clostridia.
    Groot AJ; Mengesha A; van der Wall E; van Diest PJ; Theys J; Vooijs M
    Biochem Biophys Res Commun; 2007 Dec; 364(4):985-9. PubMed ID: 17971292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor prolyl-hydroxylase: purification and assays of PHD2.
    Hewitson KS; Schofield CJ; Ratcliffe PJ
    Methods Enzymol; 2007; 435():25-42. PubMed ID: 17998047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells.
    Merighi S; Benini A; Mirandola P; Gessi S; Varani K; Simioni C; Leung E; Maclennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2007 Aug; 72(2):395-406. PubMed ID: 17488804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.